DK0833919T3 - Type F botulintoksin og anvendelse deraf - Google Patents

Type F botulintoksin og anvendelse deraf

Info

Publication number
DK0833919T3
DK0833919T3 DK96917600T DK96917600T DK0833919T3 DK 0833919 T3 DK0833919 T3 DK 0833919T3 DK 96917600 T DK96917600 T DK 96917600T DK 96917600 T DK96917600 T DK 96917600T DK 0833919 T3 DK0833919 T3 DK 0833919T3
Authority
DK
Denmark
Prior art keywords
toxin
type
botulinum toxin
fragment
fusion protein
Prior art date
Application number
DK96917600T
Other languages
Danish (da)
English (en)
Inventor
Richard William Titball
Michael James Elmore
Margaret Lamble Mauchline
Nigel Peter Minton
Vladimir Artymovich Pasechnik
Original Assignee
Health Prot Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Health Prot Agency filed Critical Health Prot Agency
Application granted granted Critical
Publication of DK0833919T3 publication Critical patent/DK0833919T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK96917600T 1995-06-12 1996-06-12 Type F botulintoksin og anvendelse deraf DK0833919T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9511909.5A GB9511909D0 (en) 1995-06-12 1995-06-12 Vaccine
PCT/GB1996/001409 WO1996041881A1 (en) 1995-06-12 1996-06-12 Type f botulinum toxin and use thereof

Publications (1)

Publication Number Publication Date
DK0833919T3 true DK0833919T3 (da) 2005-01-17

Family

ID=10775930

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96917600T DK0833919T3 (da) 1995-06-12 1996-06-12 Type F botulintoksin og anvendelse deraf

Country Status (12)

Country Link
US (1) US7041792B2 (de)
EP (1) EP0833919B1 (de)
JP (1) JP4005633B2 (de)
AT (1) ATE276366T1 (de)
AU (1) AU705944B2 (de)
CA (1) CA2224444C (de)
DE (1) DE69633389T2 (de)
DK (1) DK0833919T3 (de)
ES (1) ES2224171T3 (de)
GB (1) GB9511909D0 (de)
PT (1) PT833919E (de)
WO (1) WO1996041881A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7214787B1 (en) * 1993-09-21 2007-05-08 United States Of America As Represented By The Secretary Of The Army Recombinant vaccine against botulinum neurotoxin
DE19735105A1 (de) * 1997-08-13 1999-03-04 Univ Albert Ludwigs Freiburg Transportsystem zur Einbringung von Proteinen in Zielzellen mit Hilfe eines Fusionsproteins, Nucleinsäurekonstrukte kodierend für die Komponenten des Transportsystems und Arzneimittel, die Komponenten des Transportsystems umfassen
AU4641299A (en) * 1998-07-22 2000-02-14 Agricultural Research Council Vaccine comprising a non-toxic immunogenic derivative of (clostridium botulinum)type d neurotoxin
CA2371279A1 (en) * 1999-05-12 2000-11-16 Leonard A. Smith Recombinant vaccine against botulinum neurotoxin
US20060073208A1 (en) * 2004-10-01 2006-04-06 Allergan, Inc. Cosmetic neurotoxin compositions and methods
GB0525213D0 (en) * 2005-12-12 2006-01-18 Secr Defence Vaccine
EP2907504B1 (de) 2011-02-08 2017-06-28 Halozyme, Inc. Zusammensetzung und Lipidformulierung eines Hyaluronan-abbauenden Enzyms und seiner Verwendung zur Behandlung von benigner Prostatahyperplasie
KR102175159B1 (ko) * 2018-12-28 2020-11-05 대한민국 재조합 벡터, 형질전환 대장균, 보툴리눔 d/c형 중쇄 c말단 유래의 재조합 단백질을 포함하는 백신 조성물 및 키트
KR20250121527A (ko) 2022-12-22 2025-08-12 라이온 가부시키가이샤 칫솔

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4015911A1 (de) * 1989-09-19 1991-03-28 Max Planck Gesellschaft Impfstoff gegen die lyme-krankheit
US5736139A (en) * 1989-10-31 1998-04-07 Ochidian Pharmaceuticals, Inc. Treatment of Clostridium difficile induced disease
US6680182B1 (en) * 1992-07-31 2004-01-20 Acambis Research Limited Expression of recombinant fusion proteins in attenuated bacteria
GB9305919D0 (en) 1993-03-22 1993-05-12 Health Lab Service Board Botulinum toxin polypeptides and their use as vaccines

Also Published As

Publication number Publication date
GB9511909D0 (en) 1995-08-09
ES2224171T3 (es) 2005-03-01
AU6012196A (en) 1997-01-09
PT833919E (pt) 2005-01-31
CA2224444C (en) 2010-02-16
US7041792B2 (en) 2006-05-09
JPH11507827A (ja) 1999-07-13
WO1996041881A1 (en) 1996-12-27
CA2224444A1 (en) 1996-12-27
US20020081304A1 (en) 2002-06-27
DE69633389D1 (de) 2004-10-21
EP0833919B1 (de) 2004-09-15
EP0833919A1 (de) 1998-04-08
ATE276366T1 (de) 2004-10-15
JP4005633B2 (ja) 2007-11-07
DE69633389T2 (de) 2005-10-27
AU705944B2 (en) 1999-06-03

Similar Documents

Publication Publication Date Title
IS4345A (is) Setin N-(indól-2-karbónýl)-b-alaninamíð, notkun þeirra og lyfjaefnablöndur
TR199501669A1 (tr) Peptid ve proteinlerin aerosol formülasyonlari.
BR9607317A (pt) Peptídios e composição farmacêutica
BR9607318A (pt) Peptidos e composição farmacêutica
BR9504791B1 (pt) composto de polipeptìdeo e composição farmacêutica.
DK0981375T3 (da) Farmaceutiske præparater indeholdende plasmaprotein
EE03280B1 (et) Pidurdatud vabanemisega ravimkuulikesed ja neid sisaldav ravimpreparaat
FI955720L (fi) Urokinaasireseptoriaktiivisuuden peptidi-inhibiittoreita
DK0712931T4 (da) Interferon-gamma-produktionsinducerende polypeptid, monoklonalt antistof og middel mod sygdomme, der responderer på interferon-gamma
DZ2086A1 (fr) Benzylaminopipéridines substituées et compositionspharmaceutiques les contenant.
ATE397062T1 (de) Chimäre polypeptide, die das fragment b des shigatoxins sowie peptide von therapeutischem interesse enthalten
FI954978L (fi) Modifioidut proteiini- ja peptidilääkeaineet
DE69625506D1 (de) Schwefelsubstituierte peptide als inhibitoren für metalloproteinasen und der tnf-freisetzung
FI944802L (fi) HLE-proteiinien aktiivisuutta inhiboivat laktaamidipeptidit
FI972384L (fi) Uudet dipeptidiset p-amidinobentsyyliamidit, jotka sisältävät N-terminaalisia sulfonyyli- tai amidinosulfonyyliryhmiä
DK0833919T3 (da) Type F botulintoksin og anvendelse deraf
FR2694296B1 (fr) Peptides inhibant l'activité des protéines ras, préparation et utilisation.
FI954986L (fi) Uudet, suun kautta annettavat, syklosporiinia sisältävät farmaseuttiset valmisteet
NO980296D0 (no) Forbedrede terapeutiske midler
FI956178A0 (fi) Varsibromelaiiniproteaasin lääkekäyttö
FI946031L (fi) Kringleä sisältävien proteiinien puhdistus ja etenkin t-PA:n
FI940717A7 (fi) Streptogramiinien puhdistetut muodot, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet
FR2718028B1 (fr) Nouvelles compositions cosmétiques ou dermopharmaceutiques contenant des hydrolysats peptidiques modifiés.
DK362288A (da) Homocyclostatin- og cyclostatinholdige peptider og farmaceutiske praeparater indeholdende disse
DE69420044D1 (de) Blutregulierende peptide